Interpreting Graphs and Multi-Panel Figures - Biochemistry

SECTION 1

Historical Context & Motivation

The ability to represent experimental data graphically has been central to the biological sciences since the discipline's earliest quantitative era. Before the rise of modern graphical conventions, biochemists communicated results primarily through dense tables of numbers, making it exceedingly difficult to discern trends, compare conditions, or identify outliers. The development of graphical data representation transformed how scientists communicated findings and, more fundamentally, how they thought about biological systems. As biochemical techniques grew in complexity—from simple spectrophotometric assays to multi-dimensional proteomics experiments—the need for multi-panel figures that could convey layered, complementary datasets within a single visual narrative became paramount.

1786 • Playfair's Statistical Graphics

William Playfair published The Commercial and Political Atlas, introducing the line graph and bar chart—foundational tools still used in biochemistry today to plot kinetic data and compare experimental conditions.

1944 • Avery–MacLeod–McCarty Experiment

Oswald Avery's landmark paper identifying DNA as the transforming principle used multi-panel tables and simple graphical comparisons, foreshadowing the modern composite figure format used in molecular biology.

1958 • Lineweaver–Burk Double-Reciprocal Plots

The widespread adoption of the Lineweaver–Burk plot demonstrated how linearizing nonlinear data (Michaelis–Menten kinetics) into a graphical form could yield kinetic constants directly from visual inspection of slopes and intercepts.

1990s • Rise of Multi-Panel Figures in Journals

Journals like Cell and Nature standardized multi-panel figure formats (panels A–F or more), integrating Western blots, quantification bar charts, microscopy images, and flow cytometry histograms into single composite figures.

2010s • Data Visualization & Reproducibility Era

Growing concerns about reproducibility led to mandates for raw data display (e.g., scatter plots over bar charts), proper error bars, and supplemental figures—making graph literacy an essential competency for every biochemist.

Today, a single figure in a biochemistry paper may contain six or more panels spanning gel electrophoresis images, dose-response curves, bar charts with individual data points, and structural models. The central question this lesson addresses is: how do you systematically decode a complex, multi-panel figure to extract the experimental story and evaluate whether the data support the authors' conclusions?

SECTION 2

Core Principles of Graph Interpretation

Interpreting graphs and multi-panel figures in biochemistry requires a structured approach rather than casual visual scanning. Every graph encodes at least four dimensions of information—what is being measured, under what conditions, how variables relate to one another, and how reliable the measurements are. The following core principles provide a systematic framework for deconstructing any figure you encounter in a biochemistry journal article, textbook, or exam.

Axes Define the Experiment

Always read axis labels and units first. The independent variable (x-axis) is what the researcher controls (e.g., substrate concentration, time), while the dependent variable (y-axis) is the measured outcome (e.g., reaction velocity, fluorescence intensity). Logarithmic vs. linear scales fundamentally change how you interpret trends.

Error Bars Convey Confidence

Error bars can represent standard deviation (SD), standard error of the mean (SEM), or confidence intervals (CI). SD describes data spread; SEM describes precision of the mean estimate. Overlapping SEM bars do not necessarily mean 'no significant difference'—statistical tests (p-values) must be checked separately.

Controls Anchor Interpretation

Before evaluating experimental conditions, identify positive and negative controls. A negative control establishes baseline signal; a positive control confirms the assay is working. Without valid controls, even dramatic-looking data may be uninterpretable.

Panel Logic Tells a Story

In multi-panel figures, panels are arranged to build a logical argument—often from qualitative (e.g., gel images) to quantitative (e.g., densitometry bar charts), or from in vitro to in vivo evidence. Reading the figure legend is non-negotiable.

Scale and Context Matter

A 2-fold change may be biologically meaningless or profoundly significant depending on the system. Always ask: is the y-axis starting at zero or truncated? Is a fold-change plotted on a log₂ scale? Context from the text and legend determines whether a visual difference constitutes a real biological effect.

✦

KEY TAKEAWAY

Think of a multi-panel figure like a legal brief: each panel is a piece of evidence, the figure legend is the witness testimony, and the text is the lawyer's argument. Just as a jury must weigh each piece of evidence independently before reaching a verdict, you must evaluate each panel's data quality and internal controls before accepting the figure's overall conclusion. Skipping the axis labels is like ignoring the sworn testimony—you might reach the wrong verdict.

SECTION 3

Anatomy of a Multi-Panel Figure

The diagram below illustrates a prototypical multi-panel figure as you would encounter in a biochemistry research paper. This example figure investigates the effect of an inhibitor on enzyme activity, combining qualitative and quantitative data across four panels. Study the layout carefully—note how each panel provides a distinct type of evidence, and how the panels collectively build a logical narrative from raw observation to quantified conclusion.

A prototypical multi-panel figure from a biochemistry paper. Panel A shows qualitative evidence (Western blot showing dose-dependent loss of Enzyme Y). Panel B quantifies the gel data via densitometry with error bars and statistical markers. Panel C presents a sigmoidal dose-response curve with the IC₅₀ marked. Panel D provides the statistical summary essential for interpreting panels B and C.

Notice how the four panels in this figure work synergistically. Panel A provides the raw qualitative data—you can visually observe that the protein band at ~50 kDa diminishes as Compound X concentration increases. However, visual impressions can be deceiving, so Panel B converts those band intensities into quantitative bar chart data, complete with error bars (SEM from three replicates) and asterisks denoting statistical significance. Panel C presents the same inhibitory relationship as a continuous dose-response curve, enabling extraction of a precise IC₅₀ value (the concentration producing 50% inhibition). Finally, Panel D makes the statistical framework explicit—without knowing that error bars represent SEM, that n = 3, and that a one-way ANOVA with post-hoc correction was used, you cannot properly evaluate the strength of the evidence. This panel-by-panel logic—qualitative → quantitative → modeled → statistical—is the backbone of most biochemistry figures.

SECTION 4

Quantitative Framework: Reading Numbers from Graphs

While many biochemistry graphs are interpreted qualitatively ("the band intensity decreases"), rigorous interpretation requires extracting quantitative parameters from curves and plots. Several mathematical relationships underpin the most common graph types in biochemistry. Understanding these equations allows you to predict what a graph should look like under ideal conditions and, more importantly, to recognize when data deviate from expectation—which is often where the most interesting biology lies.

MICHAELIS–MENTEN EQUATION

v = (V_max × [S]) / (K_m + [S])

where v = initial reaction velocity, V_max = maximum velocity at saturating substrate, [S] = substrate concentration, and K_m = the Michaelis constant (substrate concentration at half V_max). This equation generates the characteristic hyperbolic curve seen in enzyme kinetics plots.

LINEWEAVER–BURK LINEARIZATION

1/v = (K_m / V_max) × (1/[S]) + 1/V_max

Plotting 1/v vs. 1/[S] yields a straight line with slope = K_m/V_max, y-intercept = 1/V_max, and x-intercept = −1/K_m. This linearized form allows graphical determination of kinetic constants and distinguishes competitive, uncompetitive, and mixed inhibition patterns.

HILL EQUATION (COOPERATIVE BINDING)

log(Y / (1 − Y)) = n × log[L] − n × log(K_d)

where Y = fractional saturation, n = Hill coefficient (n > 1 indicates positive cooperativity, n < 1 indicates negative cooperativity), [L] = ligand concentration, and K_d = apparent dissociation constant. A Hill plot (log(Y/(1−Y)) vs. log[L]) transforms a sigmoidal binding curve into a linear relationship whose slope equals n.

These equations are not merely abstract mathematics—they define the expected shapes of the graphs you will encounter. Michaelis–Menten kinetics produce hyperbolic curves; Hill-type cooperativity produces sigmoidal curves; Lineweaver–Burk transforms produce straight lines. When you see a graph in a paper, your first mental step should be to ask: "What mathematical model should describe this data, and does the data actually fit that model?" Deviations—such as a Lineweaver–Burk plot that curves rather than remaining linear—immediately signal substrate inhibition, allosteric effects, or experimental artifact, and recognizing these departures is at the heart of competent graph interpretation.

SECTION 5

Common Graph Types in Biochemistry

Biochemistry relies on a diverse repertoire of graph types, each suited to particular experimental questions. Developing fluency across these formats is essential because a single multi-panel figure may combine three or four different graph types. The following diagram and table provide a structured classification of the most commonly encountered formats, organized by the type of data they represent.

A visual catalog of six common graph types in biochemistry. Kinetic curves (hyperbolic, Michaelis–Menten), linear transforms (Lineweaver–Burk), dose-response curves (sigmoidal), bar/scatter charts with individual data points, chromatograms (absorbance vs. elution volume), and heatmaps (color-coded gene expression data).

Graph Type	Typical X-axis	Typical Y-axis	Key Feature to Look For
Michaelis–Menten	[S] (substrate conc.)	v₀ (initial velocity)	Hyperbolic saturation; plateau → V_max
Lineweaver–Burk	1/[S]	1/v₀	Line pattern distinguishes inhibition types
Dose-Response	log [drug or ligand]	% response or inhibition	Sigmoidal shape; inflection → EC₅₀ / IC₅₀
Bar + Scatter	Conditions / genotypes	Measured parameter	Individual dots show data spread; error bars ± SEM or SD
Chromatogram	Time or elution volume	Absorbance (A₂₈₀, A₂₆₀)	Peak positions, heights, and resolution between peaks
Heatmap	Conditions / samples	Genes / proteins (rows)	Color intensity → magnitude; clustering reveals patterns

Summary of common biochemistry graph types and their key interpretive features

SECTION 6

Worked Example: Deconstructing a Multi-Panel Figure

Imagine you encounter a figure in a journal article with the following panels. The authors claim that mutation R145A in Enzyme Z abolishes catalytic activity and impairs substrate binding. Walk through the systematic interpretation below to see how you would evaluate this claim panel by panel.

Interpreting a Four-Panel Figure: Mutation R145A in Enzyme Z

1
Step 1 — Read the Figure Legend

The legend states: 'Figure 3. Characterization of Enzyme Z wild-type (WT) and R145A mutant. (A) SDS-PAGE gel of purified proteins. (B) Michaelis–Menten kinetics at 25°C in 50 mM Tris-HCl pH 7.4. (C) Lineweaver–Burk plot of the same data. (D) Isothermal titration calorimetry (ITC) binding isotherms. Error bars = SEM, n = 3.' Before looking at any data, you already know the experimental conditions, the number of replicates, and the error metric.

Legend provides: buffer, temperature, n = 3, error bars = SEM
2
Step 2 — Panel A: Verify Protein Quality

Panel A shows an SDS-PAGE gel with molecular weight markers, a WT lane, and an R145A lane. Both lanes show a single band at ~45 kDa with comparable intensity. This tells you both proteins are expressed, purified to near-homogeneity, and loaded at equivalent amounts. If the R145A lane were empty or showed degradation products, all subsequent panels would be uninterpretable because you wouldn't know whether activity differences reflected the mutation or poor protein quality.

Both proteins are pure and loaded equally → downstream comparisons are valid
3
Step 3 — Panel B: Compare Kinetic Curves

Panel B plots v₀ (y-axis, µmol/min/mg) versus [S] (x-axis, mM) for WT (blue circles) and R145A (red triangles). The WT curve is a classic hyperbola saturating near V_max ≈ 120 µmol/min/mg with K_m ≈ 0.5 mM. The R145A curve hugs the x-axis, with v₀ never exceeding ~5 µmol/min/mg. You note: V_max is reduced >20-fold. But can you determine K_m for the mutant? With such low activity, the hyperbolic fit may be unreliable—the error bars on the R145A data points overlap with zero. This is where Panel C becomes critical.

V_max(R145A) ≈ 5 vs. V_max(WT) ≈ 120 µmol/min/mg → >95% activity loss confirmed
4
Step 4 — Panel C: Extract Kinetic Constants from Lineweaver–Burk

Panel C plots 1/v₀ versus 1/[S]. The WT line is well-behaved, and from the y-intercept (1/V_max ≈ 0.0083) and x-intercept (−1/K_m ≈ −2.0), you confirm V_max = 120 µmol/min/mg and K_m = 0.5 mM. The R145A line has a much steeper slope, consistent with decreased V_max and possibly increased K_m (x-intercept closer to zero, suggesting K_m ≈ 2.5 mM). However, you notice large error bars on the R145A data points in the double-reciprocal plot, especially at low [S], because taking 1/v amplifies error when v is near zero.

$K_m$ (R145A) ≈ 2.5 mM vs. $K_m$ (WT) ≈ 0.5 mM → 5-fold weaker substrate affinity. But error is large at low [S].
5
Step 5 — Panel D: Independent Binding Data (ITC)

Panel D shows ITC binding isotherms—heat released per injection versus molar ratio of substrate to enzyme. The WT isotherm shows a clear sigmoidal transition with K_d = 0.4 mM. The R145A isotherm shows minimal heat changes. This confirms that the mutation impairs binding directly, not merely catalysis. The K_d from ITC (0.4 mM) closely matches the kinetic K_m from Panel B (0.5 mM) for WT, which is expected when K_m ≈ K_d (i.e., k_cat << k₋₁). The consistency between orthogonal techniques strengthens the authors' claim.

Conclusion supported: R145A abolishes catalysis (Panel B/C) and impairs binding (Panel D), with orthogonal agreement between kinetics and ITC.

SECTION 7

Common Pitfalls and Best Practices

Even experienced researchers sometimes misinterpret graphs due to common cognitive biases and presentational tricks. Developing an awareness of these pitfalls is as important as understanding the underlying biochemistry. The table below contrasts frequent mistakes with recommended best practices for interpreting figures in biochemistry literature.

Common Pitfall	Why It's Misleading	Best Practice
Truncated y-axis	Starting the y-axis at 80% rather than 0% makes a 10% change look like a 5-fold difference visually	Check if the axis starts at zero; if truncated, mentally rescale the apparent effect size
SEM vs. SD confusion	SEM = SD/√n, so SEM bars shrink with more replicates, making data look more precise than it is	Always read the legend to identify which error metric is used; if n < 5, SD is more informative
Ignoring controls	A 'strong signal' in the experimental lane is meaningless if the negative control also shows signal (high background)	Always evaluate experimental signals relative to negative and positive controls before drawing conclusions
Cherry-picked representative images	A 'representative' Western blot or microscopy image may show the best result rather than the median	Look for quantification panels (bar charts with all replicates) that accompany representative images
Log vs. linear scale mismatch	On a log scale, equal visual spacing represents orders of magnitude, not equal differences; trends can appear linear when they are exponential	Check axis labels for 'log' notation or powers of 10; reconsider the slope interpretation accordingly
Overlapping error bars ≠ no difference	SEM error bars can overlap even when a paired t-test yields p < 0.05, because SEM bars don't account for within-subject correlation	Rely on reported p-values or confidence intervals from formal statistical tests, not visual overlap of error bars

Common graph interpretation pitfalls and how to avoid them

⚠

KEY TAKEAWAY

Think of graph interpretation like debugging code: the figure is the program output, the legend is the documentation, and the methods section is the source code. When the output looks wrong—or suspiciously perfect—you trace back through the documentation and source to find where the bug is. A truncated y-axis is like a function that returns misleading values because of a hidden offset; SEM bars on n = 2 are like error handling that silently swallows exceptions. Always read the 'source code' (methods and legend) before trusting the 'output' (the visual).

SECTION 8

Connections to Advanced Data Interpretation

The graph interpretation skills covered in this lesson form the foundation for more advanced analytical challenges you will encounter as you progress through biochemistry and into graduate-level research. Multi-panel figures in high-impact journals increasingly incorporate computational analyses, large-scale omics data, and statistical approaches that extend well beyond the basics of reading bar charts and kinetic curves. The table below maps the foundational skills from this lesson to their advanced counterparts.

Foundational Skill (This Lesson)	Advanced Extension	Where You'll Encounter It
Reading Michaelis–Menten / Lineweaver–Burk plots	Nonlinear regression with global fitting; determining k_cat/K_m (catalytic efficiency) and its thermodynamic interpretation	Enzymology courses, drug design research
Interpreting bar charts with error bars	Violin plots, box-and-whisker plots, estimation statistics (Gardner–Altman plots showing effect sizes with confidence intervals)	Systems biology, clinical biochemistry publications
Reading single-panel heatmaps	Hierarchical clustering dendrograms, principal component analysis (PCA) biplots, volcano plots for differential expression	Genomics, proteomics, and transcriptomics papers
Identifying controls in single experiments	Assessing batch effects, normalization strategies (e.g., housekeeping gene normalization in qPCR), and multiple testing correction (Bonferroni, FDR)	Any high-throughput biochemistry experiment
Interpreting dose-response curves	Four-parameter logistic (4PL) curve fitting, Hill slope analysis, synergy/antagonism assessment using combination index (CI) plots	Pharmacology, drug combination studies

Progression from foundational to advanced graph interpretation skills in biochemistry

As you advance, you will also encounter figures that integrate structural biology data (e.g., cryo-EM density maps alongside biochemical assays), single-molecule experiments (force-extension curves from optical trap experiments), and computational predictions (molecular dynamics trajectory analyses plotted as RMSD vs. time). In each case, the same fundamental approach applies: identify what the axes represent, locate the controls, assess the error and statistical framework, and then—and only then—evaluate whether the data support the authors' narrative. The complexity of the figure may increase, but the interpretive logic remains remarkably consistent.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A multi-panel figure shows a Western blot (Panel A) and a corresponding bar chart of densitometry quantification (Panel B). The Western blot shows a clear band in the control lane but no visible band in the treatment lane. However, the bar chart in Panel B shows the treatment condition at approximately 15% of control intensity with error bars. Explain why the Western blot image might appear to show zero signal while the quantification detects residual protein. What does this discrepancy teach you about relying solely on qualitative gel images?

Show answer

Western blot images are typically displayed with brightness and contrast settings optimized for the most intense bands. When a band is at 15% of control intensity, it may be below the visual detection threshold in the printed or displayed image, especially if the contrast has been adjusted to prevent the strong control band from appearing overexposed. Densitometry software, however, quantifies pixel intensity across the entire dynamic range of the original scan, detecting signal that is invisible to the eye in the adjusted image. This discrepancy underscores a critical principle: qualitative gel images are subject to display settings that can mask real signals or exaggerate weak ones. You should always prioritize the quantified data over visual impressions of gel images, and check whether the original, unadjusted image is available in supplementary materials.

Question 2: BASIC CALCULATION

A Lineweaver–Burk plot for an enzyme shows a y-intercept of 0.004 (min·mg/µmol) and an x-intercept of −5.0 mM⁻¹. Calculate V_max and K_m for this enzyme. Show your work and include units.

Show answer

From the Lineweaver–Burk equation 1/v = (K_m/V_max)(1/[S]) + 1/V_max, the y-intercept equals 1/V_max. Therefore, V_max = 1/0.004 = 250 µmol/min/mg. The x-intercept equals −1/K_m, so K_m = −1/(−5.0) = 0.2 mM. The enzyme has a relatively high catalytic capacity (V_max = 250 µmol/min/mg) and moderate substrate affinity (K_m = 0.2 mM). These values are read directly from the intercepts of the double-reciprocal plot.

Question 3: INTERMEDIATE

A dose-response curve for Drug A shows an IC₅₀ of 2 µM, while Drug B has an IC₅₀ of 200 µM. Both curves are plotted on the same graph with log [drug] on the x-axis. Drug A's Hill slope is approximately 1.0, while Drug B's Hill slope is approximately 3.0. Compare the two drugs in terms of potency and cooperativity. Which drug would you expect to show a steeper curve, and what does this imply about its mechanism of action?

Show answer

Drug A is 100-fold more potent than Drug B because its IC₅₀ is 100× lower (2 µM vs. 200 µM), meaning Drug A achieves 50% inhibition at a much lower concentration. However, Drug B has a Hill slope of 3.0 compared to Drug A's 1.0, meaning Drug B's dose-response curve is much steeper—it transitions more abruptly from minimal to maximal effect. A Hill slope of 1.0 for Drug A suggests simple, non-cooperative binding to a single site (consistent with classical competitive or non-competitive inhibition). A Hill slope of 3.0 for Drug B suggests positive cooperativity, meaning binding of one Drug B molecule facilitates binding of additional molecules, or that Drug B interacts with multiple sites on the target simultaneously. Despite Drug B's lower potency, its steep dose-response means there is a narrower concentration window between no effect and full effect, which has important implications for therapeutic dosing: Drug B would be more difficult to titrate precisely.

Question 4: APPLIED

You are reviewing a manuscript that presents a multi-panel figure claiming that siRNA knockdown of Gene X reduces cell proliferation. Panel A shows a Western blot with a loading control (β-actin). Panel B shows a bar chart of cell counts at 72 hours (control siRNA vs. Gene X siRNA, p = 0.03, n = 3). Panel C shows a growth curve over 5 days for both conditions. You notice that in Panel A, the β-actin loading control band is approximately 50% weaker in the Gene X siRNA lane compared to the control lane. How does this observation affect your interpretation of Panels B and C? What additional experiment or analysis would you request?

Show answer

The unequal β-actin loading control is a serious concern. β-actin is used as a normalization standard because its expression should be constant regardless of experimental treatment. If the β-actin band is 50% weaker in the Gene X siRNA lane, there are two possibilities: either less total protein was loaded in that lane (a technical error), or the Gene X siRNA treatment itself reduced cell number or viability such that the protein lysate was less concentrated (which would actually support the authors' claim, but in a confounded way). If the loading is truly unequal, then the apparent knockdown of Gene X protein may be overestimated—the band may look fainter simply because less total protein was loaded. Panels B and C would similarly be affected if the siRNA itself is toxic rather than specifically targeting Gene X. You should request: (1) densitometry of the Gene X band normalized to the β-actin band, showing that the knockdown persists after normalization; (2) a second loading control (e.g., total protein staining with Ponceau S or stain-free imaging); and (3) a non-targeting siRNA control and a second siRNA sequence targeting Gene X to rule out off-target toxicity.

Question 5: CRITICAL THINKING

A colleague presents a Lineweaver–Burk plot showing three lines: uninhibited enzyme, enzyme + 10 µM inhibitor, and enzyme + 50 µM inhibitor. All three lines converge at the same y-intercept (1/V_max) but have different x-intercepts and slopes. Your colleague concludes this is competitive inhibition. However, upon closer inspection, you notice that the data points at low substrate concentrations (high 1/[S] values) deviate systematically upward from the fitted lines for the inhibited conditions. Discuss: (i) whether the convergent y-intercept pattern is consistent with competitive inhibition, (ii) what the upward deviation at high 1/[S] might indicate mechanistically, and (iii) how you would test your hypothesis using a different graphical or experimental approach.

Show answer

(i) Yes, convergence at the y-intercept (same V_max) with different slopes and x-intercepts is the classic Lineweaver–Burk signature of competitive inhibition—the inhibitor increases the apparent K_m but does not affect V_max because sufficient substrate can outcompete the inhibitor. (ii) The upward deviation of data points at high 1/[S] (i.e., low [S]) from the fitted lines suggests that the Lineweaver–Burk model is not perfectly describing the data at these concentrations. This could indicate substrate inhibition at high [S] (which would bend the plot in the opposite direction), or more likely, it suggests that the inhibitor may exhibit mixed inhibition with a small uncompetitive component that only becomes apparent at very low substrate concentrations where the enzyme-substrate-inhibitor ternary complex becomes significant. Alternatively, at low [S], even small absolute errors in velocity measurements produce large errors in 1/v, so this could be an artifact of the Lineweaver–Burk transform amplifying experimental noise. (iii) To distinguish between these possibilities, you could use a Dixon plot (1/v vs. [I] at fixed [S]) or an Eadie–Hofstee plot (v vs. v/[S]), which distributes error more evenly. More rigorously, you could perform nonlinear regression fitting of the raw v vs. [S] data to competitive, uncompetitive, and mixed inhibition models and compare the fits using an F-test or AIC (Akaike Information Criterion) to determine which model best describes the data without overfitting.

SUMMARY

Lesson Summary

Summary

Interpreting graphs and multi-panel figures is a core competency in biochemistry that requires a systematic, stepwise approach. Every figure should be deconstructed by first reading the figure legend to identify experimental conditions, replicates, and error metrics. Next, identify the axis labels and scales (linear vs. logarithmic), locate positive and negative controls, and determine whether error bars represent SD, SEM, or confidence intervals. Common graph types—including Michaelis–Menten curves, Lineweaver–Burk plots, dose-response curves, bar charts with scatter overlays, chromatograms, and heatmaps—each encode specific relationships that are governed by underlying mathematical models.

In multi-panel figures, panels are arranged to build a logical argument, typically progressing from qualitative observations (e.g., gel images) to quantitative analyses (e.g., densitometry, kinetic parameters) to statistical validation. Critical evaluation requires vigilance against common pitfalls such as truncated y-axes, SEM/SD confusion, cherry-picked representative images, and the misinterpretation of overlapping error bars as evidence of no statistical difference. Mastery of these interpretive skills prepares you for advanced data visualization approaches including volcano plots, PCA biplots, and nonlinear regression analysis that are standard in modern biochemistry research.